← Every company

United Therapeutics Corp SEC Filings

What United Therapeutics Corp has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

UTHR overview →
Filings on file
115
since Oct 27, 2016
Warning signs
0
none filed
Last results
Aug 5, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Sep 8, 2026
Material agreement
8-K
Read ↗
Aug 5, 2026
Results announced
8-K
Read ↗
Aug 5, 2026
Quarterly report
10-Q
Read ↗
Jul 23, 2026
Executive or director change
8-K
Read ↗
Jun 29, 2026
Executive or director changeShareholder vote
8-K
Read ↗
May 6, 2026
Results announced
8-K
Read ↗
May 6, 2026
Quarterly report
10-Q
Read ↗
Mar 9, 2026
Material agreement
8-K
Read ↗
Feb 25, 2026
Results announced
8-K
Read ↗
Feb 25, 2026
Annual report
10-K
Read ↗
Jan 22, 2026
Executive or director change
8-K
Read ↗
Oct 29, 2025
Results announced
8-K
Read ↗
Oct 29, 2025
Quarterly report
10-Q
Read ↗
Aug 1, 2025
Material agreement
8-K
Read ↗
Jul 30, 2025
Results announced
8-K
Read ↗
Jul 30, 2025
Quarterly report
10-Q
Read ↗
Jun 27, 2025
Executive or director changeShareholder vote
8-K
Read ↗
Apr 30, 2025
Results announced
8-K
Read ↗
Apr 30, 2025
Quarterly report
10-Q
Read ↗
Apr 28, 2025
Material agreementNew debt
8-K
Read ↗
Feb 26, 2025
Results announced
8-K
Read ↗
Feb 26, 2025
Annual report
10-K
Read ↗
Oct 30, 2024
Results announced
8-K
Read ↗
Oct 30, 2024
Quarterly report
10-Q
Read ↗
Jul 31, 2024
Results announced
8-K
Read ↗
Jul 31, 2024
Quarterly report
10-Q
Read ↗
Jun 27, 2024
Executive or director changeShareholder vote
8-K
Read ↗
May 1, 2024
Results announced
8-K
Read ↗
May 1, 2024
Quarterly report
10-Q
Read ↗
Mar 29, 2024
Material agreementNew debt
8-K
Read ↗
Mar 25, 2024
Material agreement
8-K
Read ↗
Feb 21, 2024
Results announced
8-K
Read ↗
Feb 21, 2024
Annual report
10-K
Read ↗
Nov 13, 2023
Tender offer
SC TO-T
Read ↗
Nov 1, 2023
Results announced
8-K
Read ↗
Nov 1, 2023
Quarterly report
10-Q
Read ↗
Aug 2, 2023
Results announced
8-K
Read ↗
Aug 2, 2023
Quarterly report
10-Q
Read ↗
Jul 14, 2023
Shareholder vote
8-K/A
Read ↗
Jun 28, 2023
Executive or director changeShareholder vote
8-K
Read ↗
May 3, 2023
Results announced
8-K
Read ↗
May 3, 2023
Quarterly report
10-Q
Read ↗
Mar 31, 2023
Material agreementNew debt
8-K
Read ↗
Feb 22, 2023
Results announced
8-K
Read ↗
Feb 22, 2023
Annual report
10-K
Read ↗
Nov 2, 2022
Results announced
8-K
Read ↗
Nov 2, 2022
Quarterly report
10-Q
Read ↗
Aug 3, 2022
Results announced
8-K
Read ↗
Aug 3, 2022
Quarterly report
10-Q
Read ↗
Jun 28, 2022
Executive or director changeShareholder vote
8-K
Read ↗
May 4, 2022
Results announced
8-K
Read ↗
May 4, 2022
Quarterly report
10-Q
Read ↗
Apr 1, 2022
Material agreementNew debt
8-K
Read ↗
Feb 24, 2022
Results announced
8-K
Read ↗
Feb 24, 2022
Annual report
10-K
Read ↗
Nov 3, 2021
Results announced
8-K
Read ↗
Nov 3, 2021
Quarterly report
10-Q
Read ↗
Oct 1, 2021
Material agreementShareholder vote
8-K
Read ↗
Aug 4, 2021
Results announced
8-K
Read ↗
Aug 4, 2021
Quarterly report
10-Q
Read ↗
Jun 25, 2021
Executive or director changeShareholder vote
8-K
Read ↗
Jun 23, 2021
Material agreement
8-K
Read ↗
May 5, 2021
Results announced
8-K
Read ↗
May 5, 2021
Quarterly report
10-Q
Read ↗
Feb 24, 2021
Results announced
8-K
Read ↗
Feb 24, 2021
Annual report
10-K
Read ↗
Dec 2, 2020
Material agreementNew debt
8-K
Read ↗
Oct 28, 2020
Results announced
8-K
Read ↗
Oct 28, 2020
Quarterly report
10-Q
Read ↗
Sep 11, 2020
Executive or director change
8-K
Read ↗
Jul 29, 2020
Results announced
8-K
Read ↗
Jul 29, 2020
Quarterly report
10-Q
Read ↗
Jun 29, 2020
Change in controlShareholder vote
8-K
Read ↗
Apr 29, 2020
Results announced
8-K
Read ↗
Apr 29, 2020
Quarterly report
10-Q
Read ↗
Feb 26, 2020
Results announced
8-K
Read ↗
Feb 26, 2020
Annual report
10-K
Read ↗
Oct 30, 2019
Results announced
8-K
Read ↗
Oct 30, 2019
Quarterly report
10-Q
Read ↗
Jul 31, 2019
Results announced
8-K
Read ↗
Jul 31, 2019
Quarterly report
10-Q
Read ↗
Jun 28, 2019
Executive or director changeMaterial agreementNew debtShareholder vote
8-K
Read ↗
May 1, 2019
Results announced
8-K
Read ↗
May 1, 2019
Quarterly report
10-Q
Read ↗
Mar 1, 2019
Executive or director change
8-K
Read ↗
Feb 27, 2019
Results announced
8-K
Read ↗
Feb 27, 2019
Annual report
10-K
Read ↗
Jan 25, 2019
Acquisition or sale completed
8-K
Read ↗
Nov 15, 2018
Material agreement
8-K
Read ↗
Nov 1, 2018
Executive or director change
8-K
Read ↗
Oct 31, 2018
Results announced
8-K
Read ↗
Oct 31, 2018
Quarterly report
10-Q
Read ↗
Aug 1, 2018
Results announced
8-K
Read ↗
Aug 1, 2018
Quarterly report
10-Q
Read ↗
Jun 28, 2018
Executive or director changeMaterial agreementShareholder vote
8-K
Read ↗
May 2, 2018
Results announced
8-K
Read ↗
May 2, 2018
Quarterly report
10-Q
Read ↗
May 1, 2018
Material agreement
8-K
Read ↗
Feb 21, 2018
Results announced
8-K
Read ↗
Feb 21, 2018
Annual report
10-K
Read ↗
Jan 30, 2018
Material agreementNew debt
8-K
Read ↗
Dec 20, 2017
Material agreement
8-K
Read ↗
Oct 25, 2017
Results announced
8-K
Read ↗
Oct 25, 2017
Quarterly report
10-Q
Read ↗
Jul 27, 2017
Results announced
8-K
Read ↗
Jul 27, 2017
Quarterly report
10-Q
Read ↗
Jun 29, 2017
Shareholder vote
8-K
Read ↗
May 18, 2017
Material agreement
8-K
Read ↗
Apr 26, 2017
Results announced
8-K
Read ↗
Apr 26, 2017
Quarterly report
10-Q
Read ↗
Feb 22, 2017
Results announced
8-K
Read ↗
Feb 22, 2017
Annual report
10-K
Read ↗
Jan 30, 2017
Material agreementNew debt
8-K
Read ↗
Oct 27, 2016
Results announced
8-K
Read ↗
Oct 27, 2016
Quarterly report
10-Q
Read ↗

Source: United Therapeutics Corp's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on UTHR

Related datasets